Abstract

A combination of constituents for oral administration by women with polycystic ovarian syndrome includes alpha-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacture is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid. A combination of constituents for administration by either men or women to encourage increase in brain insulin levels and/or brain insulin receptor functionality also includes alpha-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10.


Claims
Download PDF
Document Preview
Document History
  • Publication: Feb 26, 2009
  • Application: Sep 14, 2007
    US US 85580807 A
  • Priority: Sep 14, 2007
    US US 85580807 A
  • Priority: Aug 22, 2007
    US US 84352507 A

Download Citation


Sign in to the Lens

Feedback